Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021
This review discusses reasons for prolonged use of anticoagulants after discharge of patients with COVID-19 without additional indication for anticoagulation. Data regarding rate of thrombotic and thromboembolic complications in patients with COVID-19 after discharge from the hospital are presented....
Saved in:
| Main Author: | I. S. Yavelov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2022-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2620 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism
by: Isabel Elías, et al.
Published: (2016-05-01) -
Anticoagulants in the treatment of superficial vein thrombosis of lower limbs: possibilities and limitations
by: I. S. Yavelov, et al.
Published: (2022-01-01) -
Safety of discontinuation of anticoagulants after venous thromboembolism: whether D-dimer level should be taken into account?
by: I. S. Yavelov
Published: (2023-01-01) -
EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON
by: V. I. Petrov, et al.
Published: (2016-12-01) -
Expanding the possibilities of treatment and prevention of venous thromboembolic complications in cancer patients. The role of oral anticoagulants
by: R. A. Bredikhin, et al.
Published: (2022-10-01)